Enhancement of Soft Tissue Sarcoma Response to Gemcitabine through Timed Administration of a Short-Acting Anti-Angiogenic Agent

• Jin Cheng,
• John Fuller,
• Regina Feldman,
• William Tap,
• Takashi Owa,
• Zvi Fuks,
• Richard Kolesnick

Affiliations

Jin Cheng

Laboratory of Signal Transduction, Memorial Sloan Kettering Cancer Center, New York, NY, USA

John Fuller

Laboratory of Signal Transduction, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Regina Feldman

Laboratory of Signal Transduction, Memorial Sloan Kettering Cancer Center, New York, NY, USA

William Tap

Sarcoma Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Takashi Owa

Oncology Business Group, Eisai Co Ltd, Koishikawa, Bunkyo-Ku, Tokyo, Japan

Zvi Fuks

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Richard Kolesnick

Laboratory of Signal Transduction, Memorial Sloan Kettering Cancer Center, New York, NY, USA